Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,760,627
-$87,948 QoQ
Shares Held
114,644
+13.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.37%
of 13F equity value
Holder Rank
#829
of 2,821 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $16,702,583 across 11 Drug Manufacturers - General names. PFE ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
18,091 | $4,552,419 | |
| 2 | PFE |
Pfizer Inc
This page
|
114,644 | $2,760,627 | |
| 3 | SNY |
Sanofi
|
63,394 | $2,704,388 | |
| 4 | LLY |
ELI LILLY & Co
|
1,690 | $2,027,036 | |
| 5 | MRK |
Merck & Co., Inc.
|
15,000 | $1,927,500 | |
| 6 | AMGN |
Amgen Inc
|
4,020 | $1,455,722 | |
| 7 | JNJ |
Johnson & Johnson
|
3,730 | $947,308 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,017 | $254,827 |
All Filings in PFE
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,760,627 | 114,644 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $2,848,575 | 101,445 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,524,187 | 101,373 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $2,396,215 | 94,043 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,886,647 | 77,832 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,596,622 | 63,008 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,542,109 | 58,127 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,746,008 | 60,332 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,729,947 | 61,828 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,963,479 | 70,756 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,856,407 | 64,481 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $2,214,130 | 66,751 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $2,393,993 | 65,267 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,543,472 | 62,340 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $2,589,669 | 50,540 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,837,963 | 42,001 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,844,015 | 35,171 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $1,652,445 | 31,919 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $22,557 | 382 | Shares | Sole | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||